April, May, and June (Q2). So late Q2 is June. At that point the amended EUA is filed. Company still has to follow through with a BLA application regardless of the EUA results.
October is early Q4. This should be reasonably underway by late Q3.
Also keep in mind the NIH fully funded the study. So they aren't funding something to see it fail.